Lithium Ion

Lithium Ion

SCHEMBL7702844

Cc1ccc2c(c1)CC[C@H](CN(C)CC(=O)[O-])[C@@H]2c1ccccc1.[Li+]

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 3/20 0.63
MTNR1A P48039 2/20 0.45
MTNR1B P49286 2/20 0.45
SIGMAR1 Q99720 2/20 0.38
TRPM5 Q9NZQ8 1/20 0.36
TACR1 P25103 1/20 0.35
HTR6 P50406 2/20 0.34
KIF11 P52732 1/20 0.34
PPARD Q03181 1/20 0.34
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
BLM P54132 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1761217 0.91 SLC6A9 (0.74) SLC6A9MTNR1AMTNR1BSIGMAR1TRPM5
SCHEMBL7709405 0.91 SLC6A9 (0.74) SLC6A9MTNR1AMTNR1BSIGMAR1TRPM5
Lithium Ion SCHEMBL7703444 0.88 SLC6A9 (0.62) SLC6A9MTNR1AMTNR1BSIGMAR1TACR1
Org-25935 SCHEMBL7704305 0.87 SLC6A9 (0.85) SLC6A9MTNR1AMTNR1BPPARD
Lithium Ion SCHEMBL7702768 0.87 SLC6A9 (0.60) SLC6A9MTNR1AMTNR1BTACR1PPARD
Org-25935 SCHEMBL7703028 0.87 SLC6A9 (0.85) SLC6A9MTNR1AMTNR1BPPARD
Lithium Ion SCHEMBL7700187 0.86 SLC6A9 (0.70) SLC6A9MTNR1AMTNR1BPPARD
Lithium Ion SCHEMBL7704091 0.85 SLC6A9 (0.69) SLC6A9MTNR1AMTNR1B
Lithium Ion SCHEMBL7704525 0.85 SLC6A9 (0.69) SLC6A9MTNR1AMTNR1BPPARDSLC6A2
Lithium Ion SCHEMBL7698462 0.85 SLC6A9 (0.69) SLC6A9MTNR1AMTNR1BTACR1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100769-B1 AMINOMETHYLCARBOXYLIC ACID DERIVATIVES AKZO NOBEL NV (NL) 2002-12-04 EP disclosed
US-6410592-B1 THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS AKZO NOBEL N.V. (NL) 2002-06-25 US disclosed